Bromelain-induced apoptosis in GI-101A breast cancer cells

Journal of Medicinal Food

Volumn 15, Issue 4, 2012, Pages 344-349

  Dhandayuthapani, Sivanesan ^a   Perez, Honey Diaz ^b   Paroulek, Alexandra ^b   Chinnakkannu, Panneerselvam ^a   Kandalam, Umadevi ^a   Jaffe, Mark ^b   Rathinavelu, Appu ^a,b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

4,6 diamino 2 phenylindole staining; apoptosis; breast cancer; bromelain; caspase 3; caspase 9; DNA fragmentation

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; BROMELAIN; CASPASE 3; CASPASE 9; CYTOKERATIN 18; DNA; ESTROGEN RECEPTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CELL NUCLEUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; BREAST NEOPLASMS; BROMELAINS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; DNA FRAGMENTATION; FEMALE; HUMANS; KERATIN-18; SIGNAL TRANSDUCTION; UP-REGULATION;

ANANAS COMOSUS;

EID: 84859049029     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2011.0145     Document Type: Article

References (25)

1. Leipner J, Saller R: Systemic enzyme therapy in oncology: effect and mode of action. Drugs 2000;59:769-780.
2. De Feo V: Ethnomedical field study in northern Peruvian Andes with particular reference to divination practices. J Ethnopharmacol 2003;85:243-256.
3. Beuth J: Proteolytic enzyme therapy in evidence-based complementary oncology: fact or fiction? Integr Cancer Ther 2008;7: 311-316.
4. Gautam SS, Mishra V, Dash V, Goyal AK, Rath G: Comparative study of extraction, purification and estimation of bromelain from stemand fruit of pineapple plant. Thai J Pharm Sci 2010;34:67-76.
5. Kelly GS: Bromelain: a literature review and discussion of its therapeutic applications. Alternat Med Rev 1998;1:243-257.
6. Maurer HR: Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci 2001;58:1234-1245.
7. Garbin F, Harrach T, Eckert K, Maurer HR: Bromelain proteinase F9 augments human lymphocyte-mediated growth inhibition of various tumor cells in vitro. Int J Oncol 1994;5:197-203.
8. Bhui K, Tyagi S, Prakash B, Shukla Y: Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells. Biofactors 2010;36:474-482.
9. Hurst J, Maniar N, Tombarkiewicz J, et al.: A novel model of a metastatic human breast tumour xenograft line. Br J Cancer 1993;68:274-276.
10. Morrissey JJ, Raney S: A metastatic breast tumor cell line, GI- 101A, is estrogen receptor positive and responsive to estrogren but resistant to tamoxifen. Cell Biol Int 1998;22:413-419.
11. MacFarlane M, Merrison W, Dinsdale D, Cohen GM: Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in Trail-induced apoptosis. J Cell Biol 2000;148:1239-1254.
12. Scott LC, Evans TRJ, Cassidy J, et al.: Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumor response. Br J Cancer 2009;101:410-417.
13. Li P, Nijhawan D, Budihardjo I, et al.: Cytochrome c and dATPdependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-489.
14. Kramer G, Erdal H, Mertens HJ, et al.: Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res 2004;64:1751-1756.
15. Linder S: Cytokeratin markers come of age. Tumour Biol 2007; 28:189-195.
16. Linder S, Havelka AM, Ueno T, Shoshan MC: Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Lett 2004;214:1-9.
17. Chou CF, Riopel CL, Rott LS, Omary MB: A significant soluble keratin fraction in 'simple' epithelial cells. Lack of an apparent phosphorylation and glycosylation role in keratin solubility. J Cell Sci 1993;105:433-444.
18. Caulin C, Salvesen GS, Oshima RG: Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997;138:1379-1394.
19. LeersMPG,Köelgen W, Björklund V, et al.: Immunocytochemical detection and mapping of cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 1999;187:567-572.
20. Uenoa T, Toi M, Biven K, Bando H, Ogawa T, Linder S: Measurement of an apoptotic product in the sera of breast cancer patients. Eur J Cancer 2003;39:769-774.
21. Olofsson MH, Ueno T, Pan Y, et al.: Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy. Clin Cancer Res 2007;13:3198-3206.
22. Peitsch MC, Polzar B, Stephan H, et al.: Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J 1993;12:371-377.
23. Liu X, Zou H, Slaughter C, Wang X: DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;18:175-184.
24. Kataoka S, Tsuruo T: Apoptosis. Oncologist 1996;1:399-401.
25. Gavreilli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.